Rocket Watch 02 - 03Dec2024Watch out for this stock in December. Potential to explode. 100% upside possible
Note: This is not a recommendation or investment advice, just a stock to watch. Do your own research.
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−139.82 USD
−15.04 M USD
0.00 USD
904.92 K
About Revelation Biosciences, Inc.
Sector
Industry
CEO
James M. Rolke
Website
Headquarters
San Diego
Founded
2019
FIGI
BBG00WH4GBZ2
Revelation Biosciences, Inc. is a clinical-stage life sciences company, which focuses on the development of immunologic-based therapies for the prevention and treatment of disease. Its product candidates include REVTx-99b, its lead therapeutic candidate being developed for allergic rhinitis and chronic nasal congestion, REVDx 501, a rapid home use diagnostic that can be used to detect any respiratory viral infection, regardless of virus type or strain, without the need for specialized instrumentation, and REVTx 200, an intranasal immunomodulator adjunct to be used in combination with an intramuscular vaccination for more complete immunity. The company was founded on November 20, 2019 and is headquartered in San Diego, CA.
Another Interesting Setup | Dollar Cost Average InRevelation Biosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of immune system therapeutics and diagnostics. The company engages in developing therapeutic product candidates, including REVTx-99b that is in a Phase Ib clinical trial for the
REVB REVERSAL REVB had seen 90% drop in 4 months. With breakout on the technicals, the daily could see a test top the LEADING A IC. If the LEADING B is even thought about, that will be close to testing the entire gapfill
BREAKTHROUGH ON REVB This stock has a few factors that lead me to believe it could make a move to the $3 judging by chart indicators.
It has been testing the BOLL and IC on the 1min and 4hour since the 15th of March.
On the daily it has broken through base IC and what is next would be the upper BOLL. What could mak
This stock -90% in 4 monthsThis stock has seem a dramatic drop in price since January. It went from $11 all the way down to $1. Lately we seen what look to be a floor. With a positive view on the market recent it’s possible we could see upward movement coming from REVB. If this stock even think about going back to IPO levels
REVB Reasons Not To Trade, Reasons to TradeThis chart is a great example of a gamble. Looking to the left, we see huge potential to return where it came from but the 40% gain today comes from no information. Nothing is driving the increase. We don't see market maker levels of volume either. They may have entered a few weeks ago on the 23
$REVBRevelation Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of immunologic-based therapeutics and diagnostics for the prevention and treatment of disease. The company's lead therapeutic candidate is REVTx-99, an intranasal immunomodulator to prevent or treat
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
Related stocks
Frequently Asked Questions
The current price of REVB is 3.21 USD — it has increased by 1.19% in the past 24 hours. Watch Revelation Biosciences, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Revelation Biosciences, Inc. stocks are traded under the ticker REVB.
REVB stock has fallen by −8.62% compared to the previous week, the month change is a 10.42% rise, over the last year Revelation Biosciences, Inc. has showed a −90.85% decrease.
We've gathered analysts' opinions on Revelation Biosciences, Inc. future price: according to them, REVB price has a max estimate of 320.00 USD and a min estimate of 21.45 USD. Watch REVB chart and read a more detailed Revelation Biosciences, Inc. stock forecast: see what analysts think of Revelation Biosciences, Inc. and suggest that you do with its stocks.
REVB reached its all-time high on Jan 5, 2022 with the price of 189,672.00 USD, and its all-time low was 2.36 USD and was reached on Mar 17, 2025. View more price dynamics on REVB chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
REVB stock is 20.40% volatile and has beta coefficient of 0.65. Track Revelation Biosciences, Inc. stock price on the chart and check out the list of the most volatile stocks — is Revelation Biosciences, Inc. there?
Today Revelation Biosciences, Inc. has the market capitalization of 2.84 M, it has decreased by −4.69% over the last week.
Yes, you can track Revelation Biosciences, Inc. financials in yearly and quarterly reports right on TradingView.
Revelation Biosciences, Inc. is going to release the next earnings report on May 19, 2025. Keep track of upcoming events with our Earnings Calendar.
REVB earnings for the last quarter are −4.98 USD per share, whereas the estimation was −10.32 USD resulting in a 51.74% surprise. The estimated earnings for the next quarter are −6.88 USD per share. See more details about Revelation Biosciences, Inc. earnings.
Revelation Biosciences, Inc. revenue for the last quarter amounts to 0.00 USD, matching the estimated figure, and no changes in revenue are expected for the next quarter.
REVB net income for the last quarter is −1.73 M USD, while the quarter before that showed −2.24 M USD of net income which accounts for 23.01% change. Track more Revelation Biosciences, Inc. financial stats to get the full picture.
No, REVB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 23, 2025, the company has 9 employees. See our rating of the largest employees — is Revelation Biosciences, Inc. on this list?
Like other stocks, REVB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Revelation Biosciences, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Revelation Biosciences, Inc. technincal analysis shows the buy rating today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Revelation Biosciences, Inc. stock shows the sell signal. See more of Revelation Biosciences, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.